What is the appropriate ondansetron (Zofran) dosage for a 3‑year‑old child weighing 47.6 lb?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron Dosing for a 3-Year-Old Weighing 47.6 lbs

For a 3-year-old child weighing 47.6 lbs (21.6 kg), administer ondansetron 0.15 mg/kg per dose, which equals approximately 3.2 mg per dose, rounded to a practical dose of 4 mg orally or intravenously. 1

Weight-Based Dosing Calculation

  • The child weighs 47.6 lbs, which converts to 21.6 kg (47.6 ÷ 2.2 = 21.6 kg)
  • The standard pediatric dose is 0.15 mg/kg per dose 2, 3
  • This calculates to 3.2 mg per dose (21.6 kg × 0.15 mg/kg = 3.24 mg)
  • Round to the nearest available tablet strength of 4 mg 1

Clinical Context-Specific Dosing

For Acute Gastroenteritis with Vomiting

  • Administer 4 mg orally as a single dose 4, 5
  • This dose can be given as an oral disintegrating tablet for ease of administration in a vomiting child 1, 5
  • The dose range of 0.13–0.26 mg/kg has been shown equally effective, so 4 mg (0.185 mg/kg for this child) falls well within the therapeutic range 5

For Food Protein-Induced Enterocolitis Syndrome (FPIES)

  • If the child is ≥6 months old with moderate-to-severe vomiting (>3 episodes), administer 0.15 mg/kg intramuscularly or intravenously, which equals 3.2 mg, with a maximum of 16 mg/dose 2
  • For mild vomiting (1–2 episodes) in children ≥6 months, consider 0.15 mg/kg intramuscularly (3.2 mg) 2

For Chemotherapy-Induced Nausea and Vomiting

  • Administer 0.15 mg/kg (3.2 mg, rounded to 4 mg) intravenously 30 minutes before chemotherapy 3
  • This can be followed by repeat doses at 4 and 8 hours after the first dose 3
  • Combining with dexamethasone significantly improves efficacy 3

Route of Administration

  • Oral route is preferred when the child can tolerate it 1, 4, 5
  • Intravenous or intramuscular routes are reserved for active vomiting or when oral administration is not feasible 2
  • Oral disintegrating tablets (4 mg) are particularly useful in young children who may have difficulty swallowing standard tablets 1, 5

Frequency and Maximum Dosing

  • For acute gastroenteritis, a single 4 mg dose is typically sufficient 4
  • If repeat dosing is needed, doses can be given every 8 hours 2
  • The maximum single dose is 16 mg 2
  • Do not exceed 3 doses in 24 hours (total 12 mg/day maximum for this indication in pediatrics) 6

Critical Safety Considerations

  • Ondansetron should be avoided if toxic megacolon is suspected in the setting of inflammatory diarrhea or diarrhea accompanied by fever 6
  • Use caution in children with heart disease due to potential QT interval prolongation 2
  • Monitor for diarrhea as a potential adverse effect, though this is generally mild 6, 3
  • Headache, constipation, and drowsiness are the most common adverse events but are typically mild to moderate 3, 7

Common Pitfalls to Avoid

  • Do not underdose by using a fixed 2 mg dose; weight-based dosing (0.15 mg/kg) is more appropriate and results in 4 mg for this child 3, 5
  • Do not use ondansetron as monotherapy for chemotherapy-induced nausea; combine with dexamethasone for moderate-to-high emetogenic risk 3
  • Do not administer if the child is under 6 months of age in the FPIES setting, as safety data are limited 2

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.